We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock

Delisted

ARAV was delisted on the 26th of January, 2024.

103 hedge funds and large institutions have $586M invested in Aravive, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 6

136% more call options, than puts

Call options by funds: $6.31M | Put options by funds: $2.68M

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

47% more capital invested

Capital invested by funds: $399M → $586M (+$187M)

37% more funds holding

Funds holding: 75103 (+28)

22% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 27

Holders
103
Holders Change
+28
Holders Change %
+37.33%
% of All Funds
2.56%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.15%
New
39
Increased
33
Reduced
27
Closed
6
Calls
$6.31M
Puts
$2.68M
Net Calls
+$3.64M
Net Calls Change
+$3.53M
Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$94.1M +$4.46M +42,272 +6%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$83.1M -$4.16M -39,417 -6%
BlackRock
3
BlackRock
New York
$50.6M +$41.5M +393,698 +37,638%
AC
4
Aisling Capital
New York
$43.2M -$8.79M -83,333 -20%
BBA
5
Baker Bros. Advisors
New York
$35.5M -$4.57M -43,375 -14%
SMV
6
Sofinnova Management VIII
California
$33.4M -$14M -133,120 -34%
Federated Hermes
7
Federated Hermes
Pennsylvania
$31M -$357K -3,381 -1%
NLVP
8
New Leaf Venture Partners
New York
$30.9M -$10.4M -98,488 -29%
JP Morgan Chase
9
JP Morgan Chase
New York
$21.8M +$2.84M +26,906 +19%
Vanguard Group
10
Vanguard Group
Pennsylvania
$21.4M +$1.79M +16,930 +11%
State Street
11
State Street
Massachusetts
$11.1M +$1.32M +12,508 +17%
KCM
12
Kingdon Capital Management
New York
$7.94M -$2.45M -23,256 -27%
Northern Trust
13
Northern Trust
Illinois
$7.77M -$57.3K -543 -0.9%
SFM
14
Sphera Funds Management
Israel
$6.41M +$879K +8,333 +20%
AG
15
Artal Group
Luxembourg
$6.41M +$5.27M +50,000 New
ACH
16
ArrowMark Colorado Holdings
Colorado
$6.19M -$1.51M -14,320 -23%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$5.5M +$1.32M +12,478 +41%
Lord, Abbett & Co
18
Lord, Abbett & Co
New Jersey
$5.4M +$4.44M +42,146 New
NTC
19
NF Trinity Capital
Hong Kong
$5.23M
Renaissance Technologies
20
Renaissance Technologies
New York
$4.58M +$2.91M +27,550 +335%
DCM
21
Driehaus Capital Management
Illinois
$4.12M +$3.39M +32,140 New
Principal Financial Group
22
Principal Financial Group
Iowa
$4M -$43.9K -416 -1%
ICM
23
ISZO Capital Management
New York
$3.98M +$3.28M +31,067 New
TCIM
24
TIAA CREF Investment Management
New York
$3.78M +$822K +7,793 +36%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$3.51M +$504K +4,778 +21%

ARAV Hedge Fund Activity: Q1 2017 in Review

103 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q1 2017, worth a combined $586M — up 47% from $399M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ARAV positions and 6 closed out — a net gain of 33 holders — while 33 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $41.5M. The largest seller was Sofinnova Management VIII, cutting an estimated $14M.

  • 103 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q1 2017, up from 75 in Q4 2016.
  • Funds reported $586M of Aravive, Inc. Common Stock stock for Q1 2017, up 47% quarter-over-quarter.
  • 39 funds opened new Aravive, Inc. Common Stock positions in Q1 2017 and 6 closed out, a net change of +33 holders.
  • The largest Aravive, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $41.5M added.
  • The largest Aravive, Inc. Common Stock seller in Q1 2017 was Sofinnova Management VIII, an estimated $14M sold.

Based on aggregated 13F filings for Q1 2017.